The New York Cannabis Control Board (CCB) recently voted to adopt updated regulations governing the state's medical cannabis program.
The updated regulations implement recent statutory changes designed to improve patient access and modernize New York’s Medical Cannabis Program. Key updates include extending patient certifications from one year to up to two years, increasing possession limits to allow patients and caregivers to possess up to a 60-day supply—or up to three ounces of cannabis and 24 grams of concentrate, whichever is greater.
Additionally, once the regulations become effective, qualifying out-of-state medical cannabis patients will also be able to purchase medical cannabis products from registered organization dispensing facilities in New York, expanding access for patients visiting the state.
The CCB also approved 24 new adult-use licenses, processed renewals and amendments, and updated medical cannabis regulations.
“Every Board meeting is an opportunity to strengthen the foundation of New York’s cannabis industry,” said Jessica García, Chair of the Cannabis Control Board. “Whether we’re modernizing the Medical Cannabis Program, approving new licenses, or refining regulations, our goal remains the same: to foster a market that serves patients, supports businesses, and protects consumers.”
The new approvals bring the total number of adult use licenses issued statewide to 2,296. New approvals include:
- Adult Use Cultivator Licenses: 15
- Adult Use Processor Licenses: 6
- Adult Use Retail Dispensary Licenses: 2
- Conditional Adult Use Retail Dispensary Licenses: 1
"Every new license represents another entrepreneur, employer, and community contributing to New York's regulated cannabis market," said John Kagia, Executive Director of the Office of Cannabis Management. "As more businesses begin operations across the state, our focus remains on creating an environment where licensees can compete fairly, operate responsibly, and build lasting businesses."
